<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Surgery induced <z:mp ids='MP_0001845'>inflammation</z:mp> is a potent promoter of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> recurrence and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The recently discovered family of Nox enzymes represent a major source of endogenous reactive oxygen species (ROS) and are now heavily implicated in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cell <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Interestingly, Nox enzymes can be 'purposefully' activated by inflammatory cytokines and growth factors which are present in abundance in the peri-operative window </plain></SENT>
<SENT sid="3" pm="."><plain>As <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells express Nox enzymes and Toll-like receptor 4 (TLR-4), we hypothesised that LPS may potentiate the ability of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells to metastasise via Nox enzyme mediated redox signalling </plain></SENT>
<SENT sid="4" pm="."><plain>In support of this hypothesis, this paper demonstrates that LPS induces a significant, transient increase of endogenous ROS in SW480, SW620 and CT-26 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells </plain></SENT>
<SENT sid="5" pm="."><plain>This increase in LPS-induced ROS activity is completely abrogated by a Nox inhibitor, diphenyleneiodonium (DPI), Nox1 siRNA and an NF-κB inhibitor, Dihydrochloride </plain></SENT>
<SENT sid="6" pm="."><plain>A significant increase in Nox1 and Nox2 protein expression occurs following LPS treatment </plain></SENT>
<SENT sid="7" pm="."><plain>Inhibition of NF-κB also attenuates the increase of Nox1 and Nox2 protein expression </plain></SENT>
<SENT sid="8" pm="."><plain>The sub-cellular location of LPS-induced ROS generation lies mainly in the endoplasmic reticulum </plain></SENT>
<SENT sid="9" pm="."><plain>LPS activates the PI3K/Akt pathway via Nox generated ROS and this signal is inhibited by DPI </plain></SENT>
<SENT sid="10" pm="."><plain>This LPS activated Nox mechanism facilitates a significant increase in SW480 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to collagen I, which is inhibited by DPI, Nox1 siRNA and a PI3K inhibitor </plain></SENT>
<SENT sid="11" pm="."><plain>Altogether, these data suggest that the LPS-Nox1 redox signalling axis plays a crucial role in facilitation of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, thus increasing the metastatic potential of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells </plain></SENT>
<SENT sid="12" pm="."><plain>Nox1 may represent a valuable target in which to prevent <z:hpo ids='HP_0003003'>colon cancer</z:hpo> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
</text></document>